Bio5C PodcastQuick Thoughts on0:00Current time: 0:00 / Total time: -28:31-28:31Paid episodeThe full episode is only available to paid subscribers of JNap’s Biotech ThoughtsSubscribe to listenQuick Thoughts onOLMA, ORIC, RLMD, SPRB, and NBP (re: OCUL/EYPT)JNapMar 09, 2026∙ Paid3ShareHello Subs!In order, this 28 min podcast covers:OLMA - The failure of Roche’s persevERA.ORIC - Ipsen pulling TazverikRLMD - Wow data!SPRB - Watching DNLI closely!NBP - VIS101 data and how it relates to KLRS, OCUL/EYPT pair-trade.Cheers!JNapSubscribeContinue reading this post for free, courtesy of JNap.Claim my free postOr purchase a paid subscription.Bio5C PodcastMy personal SubstackMy personal SubstackSubscribeListen onSubstack AppApple PodcastsSpotifyRSS FeedAppears in episodeJNapRecent EpisodesMarch 25 UpdatesMar 25 • JNapThoughts OnMar 19 • JNapFull Portfolio ReviewMar 13 • JNapAm I Crazy, or is SABS Super Interesting?Mar 11 • JNapRapid Fire Updates OnFeb 24 • JNapPreviewing OLMA's Big ProxyFeb 22 • JNapPost SOL-1 Thoughts on OCUL/EYPTFeb 20 • JNap